Instellingen beheren
MENU
Over deze site
In English
Home
Onderzoekers
Projecten
Organisaties
Publicaties
Infrastructuur
Contact
Research Explorer
Uw browser ondersteunt geen JavaScript of JavaScript is niet ingeschakeld. Zonder JavaScript kan sommige functionaliteit van deze webapplicatie uitgeschakeld zijn of foutmeldingen veroorzaken. Raadpleeg om JavaScript in te schakelen de handleiding van uw browser of contacteer uw systeembeheerder.
Onderzoeker
Ine Moors
Profiel
Projecten
Publicaties
Activiteiten
Prijzen & Erkenningen
37
Resultaten
2025
Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia
Artuur Couckuyt
Sofie Van Gassen
Annelies Emmaneel
Vince Janda
Malicorne Buysse
Ine Moors
Jan Philippé
Mattias Hofmans
Tessa Kerre
Yvan Saeys
et al.
U
Artikel in een tijdschrift
in
Cytometry Part B: Clinical Cytometry
2025
2024
Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy : a retrospective single‐centre cohort study
Emilie Janssens
Sammy Huygens
Ine Moors
Anke Delie
Tessa Kerre
Yannick Vande Weygaerde
Eva Van Braeckel
Jerina Boelens
Lieve Morbée
Alexander Schauwvlieghe
A1
Artikel in een tijdschrift
in
MYCOSES
2024
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment : the CODE stepped-wedge cluster randomized controlled trial
Dominique Benoit
Aglaja De Pauw
Celine Jacobs
Ine Moors
Fritz Offner
Anja Velghe
Nele Van Den Noortgate
Pieter Depuydt
Patrick Druwé
Dimitri Hemelsoet
et al.
A1
Artikel in een tijdschrift
in
INTENSIVE CARE MEDICINE
2024
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment : the CODE stepped-wedge cluster randomized controlled trial (Sept, 10.1007/s00134-024-07588-0, 2024)
Dominique Benoit
Aglaja De Pauw
Celine Jacobs
Ine Moors
Fritz Offner
Anja Velghe
Nele Van Den Noortgate
Pieter Depuydt
Patrick Druwé
Dimitri Hemelsoet
et al.
Correctie
2024
Diagnostic value of microbial cell-free DNA sequencing for suspected invasive fungal infections : a retrospective multicenter cohort study
Sammy Huygens
Alexander Schauwvlieghe
Nick Wlazlo
Ine Moors
Jerina Boelens
Marijke Reynders
Ga-Lai Chong
Corne H. W. Klaassen
Bart J. A Rijnders
A1
Artikel in een tijdschrift
in
OPEN FORUM INFECTIOUS DISEASES
2024
Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia
Sarah A. Potgens
Violaine Havelange
Sophie Lecop
Fuyong Li
Audrey M. Neyrinck
Florence Bindels
Nathalie Neveux
Jean-Baptiste Demoulin
Ine Moors
Tessa Kerre
et al.
A1
Artikel in een tijdschrift
in
HAEMATOLOGICA
2024
Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion : a randomized, controlled clinical trial
Glenn Van Wynsberge
Veerle Grootaert
Franky Buyle
Jens Van Praet
Roos Colman
Ine Moors
Annemie Somers
Diana Huis in 't Veld
Pieter De Cock
Kim Bigler
et al.
A1
Artikel in een tijdschrift
in
TRIALS
2024
2023
Added value of baseline chest CT scan for IPA diagnosis in AML patients receiving intensive chemotherapy : a retrospective single-centre cohort study
Sammy Huygens
Emilie Janssens
Ine Moors
Tessa Kerre
Anke Delie
Lieve Morbée
Alexander Schauwvlieghe
C3
Conferentie
2023
CYAD-01, an autologous NKG2D-based CART-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK) : haematological cohorts of the dose escalation segment of a phase 1 trial
David A. Sallman
Tessa Kerre
Violaine Havelange
Xavier Poire
Philippe Lewalle
Eunice S. Wang
Jason B. Brayer
Marco L. Davila
Ine Moors
Jean-Pascal Machiels
et al.
A1
Artikel in een tijdschrift
in
LANCET HAEMATOLOGY
2023
Clinical impact of polymerase chain reaction-based Aspergillus and azole resistance detection in invasive aspergillosis : a prospective multicenter study
Sammy Huygens
Albert Dunbar
Jochem B. Buil
Corne H. W. Klaassen
Paul E. Verweij
Karin van Dijk
Nick de Jonge
Jeroen J. W. M. Janssen
Walter J. F. M. van der Velden
Bart J. Biemond
et al.
A1
Artikel in een tijdschrift
in
CLINICAL INFECTIOUS DISEASES
2023
Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN
Philippe Decruyenaere
Dominiek Mazure
Ine Moors
Jo Van Dorpe
Malaïka Van der Linden
Barbara Denys
Mattias Hofmans
Fritz Offner
C3
Conferentie
2023
Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature
Philippe Decruyenaere
Dominiek Mazure
Ine Moors
Jo Van Dorpe
Malaïka Van der Linden
Barbara Denys
Mattias Hofmans
Fritz Offner
A1
Artikel in een tijdschrift
in
ACTA CLINICA BELGICA
2023
2022
A mini-review on aplastic anemia, illustrated by a case report on bone marrow hot pockets mimicking sclerotic bone metastases
Emilie Janssens
Jo Van Dorpe
VANESSA VAN HENDE
Ine Moors
Philip Vlummens
Ciel De Vriendt
A1
Artikel in een tijdschrift
in
ACTA CLINICA BELGICA
2022
Identification of the most important factors related to people with cancer starting a palliative care conversation : a survey study
Anne-Lore Scherrens
Kim Beernaert
Luc Deliens
Lore Lapeire
Martine De Laat
Christine Biebuyck
Karen Geboes
Charles Van Praet
Ine Moors
Benedicte Deforche
et al.
A1
Artikel in een tijdschrift
in
PSYCHO-ONCOLOGY
2022
The value of baseline chest CT scan for the diagnosis of ipa in patients with AML treated with intensive chemotherapy : a retrospective single-centre cohort study
Els Janssens
Sammy Huygens
Ine Moors
Tessa Kerre
Anke Delie
Lieve Morbée
Jerina Boelens
Alexander Schauwvlieghe
C3
Conferentie
2022
Value of baseline CT scan for early diagnosis of IPA in AML patients
Emilie Janssens
Sammy Huygens
Ine Moors
Tessa Kerre
Anke Delie
Lieve Morbée
Alexander Schauwvlieghe
C3
Conferentie
2022
2021
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : the HOVON-SAKK-132 trial
Bob Lowenberg
Thomas Pabst
Johan Maertens
Patrycja Gradowska
Bart J. Biemond
Olivier Spertini
Edo Vellenga
Laimonas Griskevicius
Lidwine W. Tick
Mojca Jongen-Lavrencic
et al.
A1
Artikel in een tijdschrift
in
BLOOD ADVANCES
2021
Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with AML and high risk MDS
Jeroen Janssen
Bob Lowenberg
Markus Manz
Mario Bargetzi
Bart Biemond
Peter von Dem Borne
Dimitri Breems
Rolf Brouwer
Yves Chalandon
Dries Deeren
et al.
A1
Artikel in een tijdschrift
in
CANCERS
2021
Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study) : a retrospective comparative cohort study
Alexander Schauwvlieghe
A. Dunbar
E. Storme
A. Vlak
R. Aerts
J. Maertens
B. Sciot
T. Van der Wel
G. Papageorgiou
Ine Moors
et al.
A1
Artikel in een tijdschrift
in
ECLINICALMEDICINE
2021
2020
Big children or small adults? Acute myeloid leukaemia (AML) treatment in adolescence and young adulthood
Karolien Maes
Barbara De Moerloose
MARIJKE QUAGHEBEUR
JOHAN DE MUNTER
Tessa Kerre
Ine Moors
A2
Artikel in een tijdschrift
in
BELGIAN JOURNAL OF HEMATOLOGY
2020
Big children or small adults? Leukaemia treatment in adolescence and young adulthood
Rutger Callens
Barbara De Moerloose
Tessa Kerre
MARIJKE QUAGHEBEUR
JOHAN DE MUNTER
Ine Moors
A2
Artikel in een tijdschrift
in
BELGIAN JOURNAL OF HEMATOLOGY
2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G. Stuessi
Y. Van Norden
P. A von dem Borne
J. Cloos
B. Gjertsen
J. J. J. W. Janssen
A. Jaspers
E. De Jongh
Ine Moors
A1
Artikel in een tijdschrift
in
LEUKEMIA
2020
Results from the phase I clinical studies evaluating Cyad-01, a first-generation NKG2D CAR T-cell product in relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome patients
David A. Sallman
A. Samer Al-Homsi
Marco L. Davila
Tessa Kerre
Ine Moors
Xavier Poire
Violaine Havelange
Philippe Lewalle
Daniel A. Pollyea
Eunice S. Wang
et al.
C3
Conferentie
2020
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
Barbara Depreter
Karin Weening
Karl Vandepoele
Magnus Essand
Barbara De Moerloose
Maria Themeli
Jacqueline Cloos
Diana Hanekamp
Ine Moors
INGE D'HONT
et al.
A1
Artikel in een tijdschrift
in
HAEMATOLOGICA
2020
2019
A case report of acute panmyelosis with myelofibRosis (APMF) with a distinct molecular pattern
Emilie De Maertelaere
Karl Vandepoele
Joni Van der Meulen
Ine Moors
Willem Daneels
Anke Delie
Jan Philippé
Carolien Bonroy
Katrien Devreese
Nadine Van Roy
et al.
C3
Conferentie
2019
Clinical implications of measurable residual disease in AML : review of current evidence
Ine Moors
Karl Vandepoele
Jan Philippé
Dries Deeren
Dominik Selleslag
Dimitri Breems
Nicole Straetmans
Tessa Kerre
Barbara Denys
A1
Artikel in een tijdschrift
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2019
Interim results from the phase I DEPLETHINK trial evaluating the infusion of a NKG2D CAR T-cell therapy post a non-myeloablative conditioning in relapse or refractory acute myeloid leukemia and myelodysplastic syndrome patients
A. Samer Al-Homsi
Enkhtsetseg Purev
Philippe Lewalle
Maher Abdul-Hay
Daniel A. Pollyea
Adriano Salaroli
Thomas Lequertier
Erik Alcantar-Orozco
Fabian Borghese
Caroline Lonez
et al.
C3
Conferentie
2019
Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients
David A. Sallman
Jason B. Brayer
Xavier Poire
Violaine Havelange
Ahmad Awada
Philippe Lewalle
Kunle Odunsi
Eunice S. Wang
Caroline Lonez
Thomas Lequertier
et al.
C3
Conferentie
2019
TARP as immunotherapeutic target in AML expressed in the LSC compartment
Barbara Depreter
Karin Weening
Karl Vandepoele
M Essand
Barbara De Moerloose
M Themeli
J Cloos
D Hanekamp
Ine Moors
INGE D'HONT
et al.
C3
Conferentie
2019
2018
A case of chronic eosinophilic leukemia with secondary transformation to acute myeloid leukemia
Mattias Hofmans
Anke Delie
Karl Vandepoele
Nadine Van Roy
Joni Van der Meulen
Jan Philippé
Ine Moors
A2
Artikel in een tijdschrift
in
LEUKEMIA RESEARCH REPORTS
2018
Blastic plasmacytoid dendritic cell neoplasm with skin, bone marrow involvement and transverse myelitis : a case report
Kameta Imaeva
Ine Moors
Jo Van Dorpe
Sofie Verbeke
Barbara Denys
A2
Artikel in een tijdschrift
in
BELGIAN JOURNAL OF HEMATOLOGY
2018
2016
Vaccination following stem cell transplantation in adults: initiatives to improve vaccination adherence and follow-up
J De Munter
M Quaghebeur
T Bauters
Ine Moors
Tessa Kerre
C3
Conferentie
2016
2015
Urgent chemotherapy in hematological patients in the ICU
Ine Moors
Frédéric Pène
Étienne Lengline
Dominique Benoit
A1
Artikel in een tijdschrift
in
CURRENT OPINION IN CRITICAL CARE
2015
2013
Proctological problems in relation to chemotherapy
Tom Lagaert
BRUNO VANDUYFHUYS
BEATRIJS STRUBBE
INGRID BRUGGEMAN
KOEN GORLEER
Pieter Hindryckx
Daan De Maeseneer
Ine Moors
Stéphanie Laurent
Karen Geboes
et al.
C3
Conferentie
2013
2009
An unusual post gastrectomy complication
Ine Moors
Harald Peeters
Wim Ceelen
Redactioneel materiaal
2009
2007
The effect of vagus nerve stimulation (VNS) on cortisol and ACTH in patients with refractory epilepsy
Veerle De Herdt
Annelies Van Dycke
Isabelle Dewaele
Ine Moors
Dirk Van Roost
Wytse Wadman
Kristl Vonck
Paul Boon
C3
Conferentie
2007
2006
Vagus nerve stimulation and cognition
Paul Boon
Ine Moors
Veerle De Herdt
Kristl Vonck
A1
Artikel in een tijdschrift
in
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
2006